YaoGeJu

Company directoryChina company filings

BrightGene Pharmaceutical Co., Ltd.

As of 18 November 2026, for the company name BrightGene Pharmaceutical Co., Ltd. as recorded, the chemical-drug catalogue lists 13 active records with this name as holder; 34 active API registrations list this name as first registered company.

Check drug filings and source records for this company-name string.

Listed by the company name as recorded in the source, without merging affiliated entities.

Page reference

CDE data as of
2026/11/18
Matching scope
Loaded public-source records only

These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/18.

Drug filings

44 acceptance records as first applicant, grouped into 18 source drug names. Source data as of 2026/11/18.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.

BGM1812注射液 · No verified English name 3 records · Latest accepted 2026/10/22

Supplement · 2New drug · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CXHB2600443Supplement2026/10/22BrightGene Pharmaceutical Co., Ltd.CDE ↗
CXHB2600442Supplement2026/10/22BrightGene Pharmaceutical Co., Ltd.CDE ↗
CXHL2500946New drug2025/09/03BrightGene Pharmaceutical Co., Ltd.CDE ↗
BGM0504片 · No verified English name 9 records · Latest accepted 2026/07/29

New drug · 6Supplement · 3

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CXHL2600931New drug2026/07/29BrightGene Pharmaceutical Co., Ltd.CDE ↗
CXHL2600930New drug2026/07/29BrightGene Pharmaceutical Co., Ltd.CDE ↗
CXHL2600929New drug2026/07/29BrightGene Pharmaceutical Co., Ltd.CDE ↗
CXHB2600105Supplement2026/04/10BrightGene Pharmaceutical Co., Ltd.; Hua Yi Tai Kang Pharma Co., Ltd. romanizedCDE ↗
CXHB2600104Supplement2026/04/10BrightGene Pharmaceutical Co., Ltd.; Hua Yi Tai Kang Pharma Co., Ltd. romanizedCDE ↗
CXHB2600103Supplement2026/04/10BrightGene Pharmaceutical Co., Ltd.; Hua Yi Tai Kang Pharma Co., Ltd. romanizedCDE ↗
CXHL2500681New drug2025/07/10BrightGene Pharmaceutical Co., Ltd.CDE ↗
CXHL2500680New drug2025/07/10BrightGene Pharmaceutical Co., Ltd.CDE ↗
CXHL2500679New drug2025/07/10BrightGene Pharmaceutical Co., Ltd.CDE ↗
BGM0504注射液 · No verified English name 10 records · Latest accepted 2026/06/11

New drug · 4Supplement · 6

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CXHS2600089New drug2026/06/11BrightGene Pharmaceutical Co., Ltd.CDE ↗
CXHS2600088New drug2026/06/11BrightGene Pharmaceutical Co., Ltd.CDE ↗
CXHS2600087New drug2026/06/11BrightGene Pharmaceutical Co., Ltd.CDE ↗
CXHS2600086New drug2026/06/11BrightGene Pharmaceutical Co., Ltd.CDE ↗
CXHB2600002Supplement2026/01/06BrightGene Pharmaceutical Co., Ltd.CDE ↗
CXHB2600001Supplement2026/01/06BrightGene Pharmaceutical Co., Ltd.CDE ↗
CXHB2500317Supplement2025/12/02BrightGene Pharmaceutical Co., Ltd.CDE ↗
CXHB2500316Supplement2025/12/02BrightGene Pharmaceutical Co., Ltd.CDE ↗
CXHB2500315Supplement2025/12/02BrightGene Pharmaceutical Co., Ltd.CDE ↗
CXHB2500314Supplement2025/12/02BrightGene Pharmaceutical Co., Ltd.CDE ↗
Salmeterol Xinafoate and Fluticasone Propionate Powder for Inhalation 2 records · Latest accepted 2026/01/22

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2600253Generic2026/01/22BrightGene Pharmaceutical Co., Ltd.CDE ↗
CYHS2600252Generic2026/01/22BrightGene Pharmaceutical Co., Ltd.CDE ↗
Oseltamivir Phosphate Capsules 1 records · Latest accepted 2026/01/21

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2600127Supplement2026/01/21BrightGene Pharmaceutical Co., Ltd.CDE ↗
Ethyl Iosapentate Capsules 2 records · Latest accepted 2025/04/29

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2501609Generic2025/04/29BrightGene Pharmaceutical Co., Ltd.CDE ↗
CYHS2404522Generic2024/12/26BrightGene Pharmaceutical Co., Ltd.CDE ↗
伏环孢素软胶囊 · No verified English name 1 records · Latest accepted 2025/01/27

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHL2500031Generic2025/01/27BrightGene Pharmaceutical Co., Ltd.CDE ↗
Ferric Carboxymaltose Injection 1 records · Latest accepted 2025/01/27

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2500520Generic2025/01/27BrightGene Pharmaceutical Co., Ltd.CDE ↗
Entecavir Tablets 4 records · Latest accepted 2024/02/09

Supplement · 4

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2400255Supplement2024/02/09BrightGene Pharmaceutical Co., Ltd.; Hua Yi Tai Kang Pharma Co., Ltd. romanizedCDE ↗
CYHB2400254Supplement2024/02/09BrightGene Pharmaceutical Co., Ltd.; Hua Yi Tai Kang Pharma Co., Ltd. romanizedCDE ↗
CYHB2201586Supplement2022/09/03BrightGene Pharmaceutical Co., Ltd.; Hua Yi Tai Kang Pharma Co., Ltd. romanizedCDE ↗
CYHB2201585Supplement2022/09/03BrightGene Pharmaceutical Co., Ltd.; Hua Yi Tai Kang Pharma Co., Ltd. romanizedCDE ↗
Iopromide Injection 2 records · Latest accepted 2023/10/08

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2302630Generic2023/10/08BrightGene Pharmaceutical Co., Ltd.CDE ↗
CYHS2302629Generic2023/10/08BrightGene Pharmaceutical Co., Ltd.CDE ↗
磷酸奥司他韦干糖浆 · No verified English name 1 records · Latest accepted 2023/08/21

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2301854Supplement2023/08/21BrightGene Pharmaceutical Co., Ltd.CDE ↗
Regadenoson Injection 1 records · Latest accepted 2023/08/12

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2302096Generic2023/08/12BrightGene Pharmaceutical Co., Ltd.CDE ↗
Dienogest Tablets 1 records · Latest accepted 2023/02/20

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2300580Generic2023/02/20BrightGene Pharmaceutical Co., Ltd.; ZHEJIANG XIANJU PHARMACEUTICAL CO., LTD.CDE ↗
Cinacalcet Hydrochloride Tablets 1 records · Latest accepted 2022/02/17

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2200322Generic2022/02/17BrightGene Pharmaceutical Co., Ltd.CDE ↗
Fondaparinux Sodium Injection 1 records · Latest accepted 2022/01/27

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2200201Generic2022/01/27BrightGene Pharmaceutical Co., Ltd.CDE ↗
硫酸阿托品滴眼液 · No verified English name 2 records · Latest accepted 2022/01/21

New drug · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CXHL2200035New drug2022/01/21BrightGene Pharmaceutical Co., Ltd.CDE ↗
CXHL2200034New drug2022/01/21BrightGene Pharmaceutical Co., Ltd.CDE ↗
Carboprost Tromethamine Injection 1 records · Latest accepted 2022/01/13

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2200070Generic2022/01/13BrightGene Pharmaceutical Co., Ltd.; Jiangxi Ai Shi Te Pharmaceutical Co., Ltd. romanizedCDE ↗
Eribulin Mesilate Injection 1 records · Latest accepted 2021/07/21

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2101455Generic2021/07/21BrightGene Pharmaceutical Co., Ltd.; Wuxi Zi Shan Pharma Co., Ltd. romanizedCDE ↗

Changes in the last 90 days

4 events from 2026/08/22 to 2026/11/19. CDE data as of 2026/11/18; NMPA data as of 2026/11/19.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.

Accepted: 2 applicationsNo longer listed under review: 2 applications

  1. 2026/11/14No longer listed under review

    Ethyl Iosapentate Capsules

    CYHS2501609

    Fact date: 2026/11/14 · Date added to this site: 2026/11/14

    Accepted: 2025/04/29

    no longer on the CDE under-review list as of the data cut-off; the review / approval outcome is to be checked

    View source ↗
  2. 2026/11/14No longer listed under review

    Ethyl Iosapentate Capsules

    CYHS2404522

    Fact date: 2026/11/14 · Date added to this site: 2026/11/14

    Accepted: 2024/12/26

    no longer on the CDE under-review list as of the data cut-off; the review / approval outcome is to be checked

    View source ↗
  3. 2026/10/22Accepted

    BGM1812注射液 · No verified English name

    CXHB2600443

    Fact date: 2026/10/22 · Date added to this site: 2026/10/22

    View source ↗
  4. 2026/10/22Accepted

    BGM1812注射液 · No verified English name

    CXHB2600442

    Fact date: 2026/10/22 · Date added to this site: 2026/10/22

    View source ↗

Under review

9 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/18.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Under review
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
BGM1812注射液 · No verified English name CXHB2600443Supplement2026/10/22BrightGene Pharmaceutical Co., Ltd.CDE ↗
BGM1812注射液 · No verified English name CXHB2600442Supplement2026/10/22BrightGene Pharmaceutical Co., Ltd.CDE ↗
BGM0504注射液 · No verified English name CXHS2600089New drug2026/06/11BrightGene Pharmaceutical Co., Ltd.CDE ↗
BGM0504注射液 · No verified English name CXHS2600088New drug2026/06/11BrightGene Pharmaceutical Co., Ltd.CDE ↗
BGM0504注射液 · No verified English name CXHS2600087New drug2026/06/11BrightGene Pharmaceutical Co., Ltd.CDE ↗
BGM0504注射液 · No verified English name CXHS2600086New drug2026/06/11BrightGene Pharmaceutical Co., Ltd.CDE ↗
Salmeterol Xinafoate and Fluticasone Propionate Powder for Inhalation CYHS2600253Generic2026/01/22BrightGene Pharmaceutical Co., Ltd.CDE ↗
Salmeterol Xinafoate and Fluticasone Propionate Powder for Inhalation CYHS2600252Generic2026/01/22BrightGene Pharmaceutical Co., Ltd.CDE ↗
Ferric Carboxymaltose Injection CYHS2500520Generic2025/01/27BrightGene Pharmaceutical Co., Ltd.CDE ↗

Catalogue holder records

13 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/18. Manufacturer-only records are excluded.

DrugMarketing authorization holderManufacturerApproval numberApprovedCatalogue category (source text)View source
Iopromide InjectionBrightGene Pharmaceutical Co., Ltd.BrightGene Pharmaceutical Co., Ltd.国药准字H202540862025/05/13Generic approved under the new chemical-drug registration classificationCDE ↗
Iopromide InjectionBrightGene Pharmaceutical Co., Ltd.BrightGene Pharmaceutical Co., Ltd.国药准字H202540852025/05/13Generic approved under the new chemical-drug registration classificationCDE ↗
Dienogest TabletsBrightGene Pharmaceutical Co., Ltd.ZHEJIANG XIANJU PHARMACEUTICAL CO., LTD.国药准字H202494682024/12/01Generic approved under the new chemical-drug registration classificationCDE ↗
Carboprost Tromethamine InjectionBrightGene Pharmaceutical Co., Ltd.Jiangxi Ai Shi Te Pharmaceutical Co., Ltd. romanized国药准字H202433362024/03/12Generic approved under the new chemical-drug registration classificationCDE ↗
磷酸奥司他韦颗粒 · No verified English nameBrightGene Pharmaceutical Co., Ltd.BrightGene Pharmaceutical Co., Ltd.国药准字H202346942023/12/26Generic approved under the new chemical-drug registration classificationCDE ↗
Eribulin Mesilate InjectionBo Rui Pharmaceutical (Suzhou) Co., Ltd. romanizedWuxi Taxus Pharmaceutical Co., Ltd国药准字H202332232023/02/28Generic approved under the new chemical-drug registration classificationCDE ↗
Voriconazole for InjectionBrightGene Pharmaceutical Co., Ltd.BrightGene Pharmaceutical Co., Ltd.国药准字H202330692023/01/19Generic approved under the new chemical-drug registration classificationCDE ↗
Oseltamivir Phosphate For Oral SuspensionBrightGene Pharmaceutical Co., Ltd.BrightGene Pharmaceutical Co., Ltd.国药准字H202234022022/06/16Generic approved under the new chemical-drug registration classificationCDE ↗
Argatroban InjectionBrightGene Pharmaceutical Co., Ltd.BrightGene Pharmaceutical Co., Ltd.国药准字H202230942022/03/01Generic approved under the new chemical-drug registration classificationCDE ↗
Entecavir TabletsBrightGene Pharmaceutical Co., Ltd.Hua Yi Tai Kang Pharma Co., Ltd. romanized国药准字H202230112022/01/11Generic approved under the new chemical-drug registration classificationCDE ↗
Entecavir TabletsBrightGene Pharmaceutical Co., Ltd.Hua Yi Tai Kang Pharma Co., Ltd. romanized国药准字H202230102022/01/11Generic approved under the new chemical-drug registration classificationCDE ↗
Oseltamivir Phosphate CapsulesBrightGene Pharmaceutical Co., Ltd.BrightGene Pharmaceutical Co., Ltd.国药准字H202136192021/07/28Generic approved under the new chemical-drug registration classificationCDE ↗
Micafungin Sodium for InjectionBrightGene Pharmaceutical Co., Ltd.BrightGene Pharmaceutical Co., Ltd.国药准字H202031552021/06/24Drug that passed quality-and-efficacy consistency evaluationCDE ↗

Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.

API registrations

34 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/18.

NameCompany / applicantRegistration numberStatusSource update dateView source
BGM0504 · No verified English nameBrightGene Pharmaceutical Co., Ltd.Y20260000372I2026/04/30CDE ↗
盐酸曲恩汀 · No verified English nameBrightGene Pharmaceutical Co., Ltd.Y20250001390I2025/12/25CDE ↗
芦比替定 · No verified English nameBrightGene Pharmaceutical Co., Ltd.Y20250000347I2025/04/11CDE ↗
麦考酚钠 · No verified English nameBrightGene Pharmaceutical Co., Ltd.Y20240001416A2026/05/21CDE ↗
羧基麦芽糖铁 · No verified English nameBrightGene Pharmaceutical Co., Ltd.Y20240001430I2024/12/24CDE ↗
肾上腺素 · No verified English nameBrightGene Pharmaceutical Co., Ltd.Y20230001214A2025/05/28CDE ↗
重酒石酸间羟胺 · No verified English nameBrightGene Pharmaceutical Co., Ltd.Y20230000701A2025/04/09CDE ↗
盐酸多巴胺 · No verified English nameBrightGene Pharmaceutical Co., Ltd.Y20230000687A2025/01/06CDE ↗
重酒石酸去甲肾上腺素 · No verified English nameBrightGene Pharmaceutical Co., Ltd.Y20230000409A2024/11/29CDE ↗
碘普罗胺 · No verified English nameBrightGene Pharmaceutical Co., Ltd.Y20230000628A2025/05/24CDE ↗
硫酸艾沙康唑 · No verified English nameBrightGene Pharmaceutical Co., Ltd.Y20230000572A2025/03/14CDE ↗
瑞加诺生 · No verified English nameBrightGene Pharmaceutical Co., Ltd.Y20230000573A2025/03/25CDE ↗
地诺孕素 · No verified English nameBrightGene Pharmaceutical Co., Ltd.Y20220000618A2025/01/09CDE ↗
舒更葡糖钠 · No verified English nameBrightGene Pharmaceutical Co., Ltd.Y20220000191A2025/05/30CDE ↗
艾地骨化醇 · No verified English nameBrightGene Pharmaceutical Co., Ltd.Y20220000173A2026/06/03CDE ↗
依维莫司 · No verified English nameBrightGene Pharmaceutical Co., Ltd.Y20210001286A2025/05/31CDE ↗
溴夫定 · No verified English nameBrightGene Pharmaceutical Co., Ltd.Y20210001219A2025/07/29CDE ↗
硫酸阿托品 · No verified English nameBrightGene Pharmaceutical Co., Ltd.Y20210001099A2024/01/23CDE ↗
卡前列素氨丁三醇 · No verified English nameBrightGene Pharmaceutical Co., Ltd.Y20210000614A2024/04/13CDE ↗
甲磺酸艾立布林 · No verified English nameBrightGene Pharmaceutical Co., Ltd.Y20210000505A2023/03/24CDE ↗
吡美莫司 · No verified English nameBrightGene Pharmaceutical Co., Ltd.Y20210000257A2024/04/19CDE ↗
富马酸丙酚替诺福韦 · No verified English nameBrightGene Pharmaceutical Co., Ltd.Y20200000740A2025/06/07CDE ↗
泊沙康唑 · No verified English nameBrightGene Pharmaceutical Co., Ltd.Y20190021534A2025/10/14CDE ↗
恩替卡韦 · No verified English nameBrightGene Pharmaceutical Co., Ltd.Y20190021456A2026/08/25CDE ↗
米卡芬净钠 · No verified English nameBrightGene Pharmaceutical Co., Ltd.Y20190021178A2024/04/19CDE ↗
恩替卡韦 · No verified English nameBrightGene Pharmaceutical Co., Ltd.Y20190001707A2025/04/04CDE ↗
磷酸奥司他韦 · No verified English nameBrightGene Pharmaceutical Co., Ltd.Y20180001370A2026/05/08CDE ↗
盐酸帕罗西汀 · No verified English nameBrightGene Pharmaceutical Co., Ltd.Y20170000926A2023/06/13CDE ↗
米卡芬净钠 · No verified English nameBrightGene Pharmaceutical Co., Ltd.Y20170000763A2023/12/27CDE ↗
磺达肝癸钠 · No verified English nameBrightGene Pharmaceutical Co., Ltd.Y20170000761A2026/01/10CDE ↗
艾司奥美拉唑钠 · No verified English nameBrightGene Pharmaceutical Co., Ltd.Y20170000673A2023/07/26CDE ↗
醋酸卡泊芬净 · No verified English nameBrightGene Pharmaceutical Co., Ltd.Y20170000599A2024/08/29CDE ↗
奥拉西坦 · No verified English nameBrightGene Pharmaceutical Co., Ltd.Y20170000585A2023/07/26CDE ↗
阿加曲班 · No verified English nameBrightGene Pharmaceutical Co., Ltd.Y20170000226A2025/01/04CDE ↗

Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.

Co-applicant records

28 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/18.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Co-applicant records
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
地塞米松眼用混悬注射液 · No verified English name CYHS2602155Generic2026/08/28Suzhou Ou Kang Wei Shi Bio Technology Co., Ltd. romanized; BrightGene Pharmaceutical Co., Ltd.CDE ↗
Fondaparinux Sodium Injection CYHB2601004Supplement2026/05/27Anhui Jia He Pharma Co., Ltd. romanized; BrightGene Pharmaceutical Co., Ltd.CDE ↗
Caspofungin Acetate for Injection CYHB2600325Supplement2026/02/11Guangzhou Yi Pin Hong Pharmaceutical Co., Ltd. romanized; BrightGene Pharmaceutical Co., Ltd.CDE ↗
Caspofungin Acetate for Injection CYHB2600324Supplement2026/02/11Guangzhou Yi Pin Hong Pharmaceutical Co., Ltd. romanized; BrightGene Pharmaceutical Co., Ltd.CDE ↗
Ioversol Injection CYHS2502389Generic2025/07/05Anhui Jia He Pharma Co., Ltd. romanized; BrightGene Pharmaceutical Co., Ltd.CDE ↗
Ioversol Injection CYHS2500275Generic2025/01/14Shandong Qidu Pharmaceutical Co., Ltd.; BrightGene Pharmaceutical Co., Ltd.CDE ↗
Fondaparinux Sodium Injection CYHB2500109Supplement2025/01/14Di Kang Bei (Suzhou) Biopharmaceuticals Technology Co., Ltd. romanized; BrightGene Pharmaceutical Co., Ltd.CDE ↗
噻托溴铵吸入喷雾剂 · No verified English name CYHS2500201Generic2025/01/10Ai Te Mei (Suzhou) Pharmaceuticals Technology Co., Ltd. romanized; BrightGene Pharmaceutical Co., Ltd.CDE ↗
噻托溴铵奥达特罗吸入喷雾剂 · No verified English name CYHS2404540Generic2024/12/26Ai Te Mei (Suzhou) Pharmaceuticals Technology Co., Ltd. romanized; BrightGene Pharmaceutical Co., Ltd.CDE ↗
Isavuconazonium Sulfate for Injection CYHS2404300Generic2024/12/11Shang Yao Dong Ying (Jiangsu) Pharma Co., Ltd. romanized; BrightGene Pharmaceutical Co., Ltd.CDE ↗
Polymyxin B sulfate for Injection CYHS2404145Generic2024/12/03Shandong Xu Lie Bio Technology Co., Ltd. romanized; BrightGene Pharmaceutical Co., Ltd.CDE ↗
磷酸奥司他韦颗粒 · No verified English name CYHB2401699Supplement2024/10/24Jiangsu Xin Li Yuan Biopharmaceutical Co., Ltd. romanized; BrightGene Pharmaceutical Co., Ltd.CDE ↗
Cinacalcet Hydrochloride Tablets CYHB2401401Supplement2024/09/10Zhengzhou Tai Feng Pharmaceutical Co., Ltd. romanized; Bo Rui Pharmaceutical (Suzhou) Co., Ltd. romanizedCDE ↗
磷酸奥司他韦颗粒 · No verified English name CYHB2400978Supplement2024/07/04Jiangsu Xin Li Yuan Biopharmaceutical Co., Ltd. romanized; BrightGene Pharmaceutical Co., Ltd.CDE ↗
吸入用布地奈德混悬液 · No verified English name CYHS2401818Generic2024/06/18Ai Te Mei (Suzhou) Pharmaceuticals Technology Co., Ltd. romanized; BrightGene Pharmaceutical Co., Ltd.CDE ↗
Oseltamivir Phosphate For Oral Suspension CYHB2400685Supplement2024/05/22Guangzhou Nan Xin Pharmaceutical Co., Ltd. romanized; BrightGene Pharmaceutical Co., Ltd.CDE ↗
Metaraminol Tartrate Injection CYHS2401477Generic2024/05/17Guangzhou Hui Feng De Bio Technology Co., Ltd. romanized; BrightGene Pharmaceutical Co., Ltd.CDE ↗
Norepinephrine Bitartrate Injection CYHS2400143Generic2024/01/10Guangzhou Hui Feng De Bio Technology Co., Ltd. romanized; BrightGene Pharmaceutical Co., Ltd.CDE ↗
吸入用布地奈德混悬液 · No verified English name CYHS2302443Generic2023/09/11Ai Te Mei (Suzhou) Pharmaceuticals Technology Co., Ltd. romanized; BrightGene Pharmaceutical Co., Ltd.CDE ↗
Everolimus Tablets CYHS2201796Generic2022/10/21Di Kang Bei (Suzhou) Biopharmaceuticals Technology Co., Ltd. romanized; BrightGene Pharmaceutical Co., Ltd.CDE ↗
磷酸奥司他韦干糖浆 · No verified English name CYHS2200631Generic2022/04/22Di Kang Bei (Suzhou) Biopharmaceuticals Technology Co., Ltd. romanized; BrightGene Pharmaceutical Co., Ltd.CDE ↗
磷酸奥司他韦干糖浆 · No verified English name CYHS2200630Generic2022/04/22Di Kang Bei (Suzhou) Biopharmaceuticals Technology Co., Ltd. romanized; BrightGene Pharmaceutical Co., Ltd.CDE ↗
Caspofungin Acetate for Injection CYHS2101499Generic2021/07/30Guangzhou Yi Pin Hong Pharmaceutical Co., Ltd. romanized; BrightGene Pharmaceutical Co., Ltd.CDE ↗
Caspofungin Acetate for Injection CYHS2101498Generic2021/07/30Guangzhou Yi Pin Hong Pharmaceutical Co., Ltd. romanized; BrightGene Pharmaceutical Co., Ltd.CDE ↗
Fondaparinux Sodium Injection CYHS2100212Generic2021/02/21Shenyang Shuang Ding Pharmaceutical Co., Ltd. romanized; BrightGene Pharmaceutical Co., Ltd.CDE ↗
Caspofungin Acetate for Injection CYHB2101006Supplement2021/02/18Hainan Hai Ling Chemical Pharmaceutical Co., Ltd. romanized; BrightGene Pharmaceutical Co., Ltd.CDE ↗
Caspofungin Acetate for Injection CYHB2101005Supplement2021/02/18Hainan Hai Ling Chemical Pharmaceutical Co., Ltd. romanized; BrightGene Pharmaceutical Co., Ltd.CDE ↗
Fondaparinux Sodium Injection CYHB2100187Supplement2021/01/28Yang Zi Jiang Pharma Group Jiangsu Zi Long Pharma Co., Ltd. romanized; BrightGene Pharmaceutical Co., Ltd.CDE ↗

How current is each source?

CDE acceptances and review
Last successful update: 2026/11/18 · Current coverage may be incomplete
Chemical-drug catalogue
Last successful update: 2026/11/18
API registrations
Last successful update: 2026/11/18
NMPA drug delivery notices
Last successful update: 2026/11/19

Loaded notices dated 2026-11-05 to 2026-11-19; 0 notices not yet loaded. Covers loaded notices only, not a complete historical approval database.

Listed by the company name as recorded in the source, without merging affiliated entities.

This page summarizes loaded records only. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.

Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.

Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.

Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.